கலேற சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from கலேற சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In கலேற சிகிச்சை Today - Breaking & Trending Today
COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Bi ....
COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru, Galera, Sorrento, Xenothera, and Many Others texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
St. Louis biotech startup Wugen raises $172M to advance its cancer-fighting therapies bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
E-Mail IMAGE: The experimental drug avasopasem manganese protects healthy tissue while enhancing radiation s capacity to kill cancerous tumor cells by converting superoxide to hydrogen peroxide. view more Credit: Michael Story, Ph.D. DALLAS - May 20, 2021 - An experimental drug that has shown promise in protecting healthy tissue from collateral damage caused by radiation therapy for cancer also appears to enhance radiation s capacity to kill tumors, a new study led by UT Southwestern scientists shows. The findings, published online in Science Translational Medicine, could provide a much-needed boost to the radiation treatments used against a variety of tumor types. The drug, avasopasem manganese (AVA), has already shown promise in clinical trials to prevent a side effect known as acute mucositis. This condition commonly occurs in head and neck cancer patients when radiation therapy damages mucous membranes. However, for this drug to become part o ....